Anti Ageing

©Getty Images - Ildo Frazao

FDA’s takedown of NMN raises fairness, transparency concerns

By Hank Schultz

NMN, an anti-aging ingredient, has been disallowed by FDA because of its prior investigation as a drug. The determination, which came as something of a surprise given the ingredient’s market history, has raised questions of fairness and transparency.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All